# UTEBZI
> **NDA215960** · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 2026-06-17
## Drug
- **FDA Application Number:** NDA215960
- **Application type:** New Drug Application
- **Brand name:** UTEBZI
- **Generic name:** Tebipenem Pivoxil Hydrobromide
- **Active ingredients:** TEBIPENEM PIVOXIL HYDROBROMIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GLAXOSMITHKLINE
- **First approval:** 2026-06-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215960)
---
*MORVS · CC0 1.0*